ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Combination long-acting muscarinic antagonist/long-acting beta agonist inhalers for COPD

Combination long-acting muscarinic antagonist/long-acting beta agonist inhalers for COPD
Agents Brand names Dosing
Combination long-acting muscarinic antagonist/long-acting beta agonist inhalers
Aclidinium 400 mcg/formoterol 12 mcg

Duaklir Genuair (Canada)

Duaklir Pressair (United States)		 1 inhalation twice daily; DPI
Glycopyrrolate 50 mcg/indacaterol 110 mcg* Ultibro Breezhaler (Canada) 1 capsule (inhalation only), once daily; DPI
Glycopyrrolate 9 mcg/formoterol 4.8 mcg Bevespi Aerosphere (United States) 2 inhalations twice daily; pMDI
Tiotropium 2.5 mcg/olodaterol 2.5 mcg per actuation

Stiolto Respimat (United States)

Inspiolto Respimat (Canada)		 2 inhalations once daily; SMI
Umeclidinium 62.5 mcg/vilanterol 25 mcg Anoro Ellipta (United States and Canada) 1 inhalation once daily; DPI
Triple combination glucocorticoid/long-acting muscarinic antagonist/long-acting beta agonist inhaler
Fluticasone furoate 100 mcg/umeclidinium 62.5 mcg/vilanterol 25 mcg Trelegy Ellipta (United States) 1 inhalation once daily; DPI
Budesonide 160 mcg/glycopyrrolate 9 mcg/4.8 mcg formoterol Breztri Aerosphere (United States and Canada) 2 inhalations twice daily; MDI
Strength shown following each ingredient in the combination is for one inhalation or puff as listed in the United States approved prescribing information or Canada product monograph.
DPI: dry powder inhaler; pMDI: pressurized metered dose inhaler; SMI: soft mist inhaler.
* Glycopyrrolate 15.6 mcg/indacaterol 27.5 mcg (Utibron Neohaler), although approved by the US Food and Drug Administration, is not available in the United States.
Graphic 116691 Version 4.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟